CHEMED CORP
About CHEMED CORP
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $2.5B
- Net income
- $265.2M
- Total assets
- $1.5B
- Market cap
- $5.9B
- Gross margin
- 32.5%
- Operating margin
- 13.4%
- Net margin
- 10.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.5B
- Cost of revenue
- $1.7B
- Gross profit
- $823.2M
- Operating expenses
- $2.2B
- Operating income
- $338.2M
- Income tax
- $90.5M
- Net income
- $265.2M
- EPS (basic)
- $18.42
- EPS (diluted)
- $18.34
Balance sheet
- Total assets
- $1.5B
- Current assets
- $302.6M
- Total liabilities
- $558.8M
- Current liabilities
- $287.1M
- Shareholders’ equity
- $979.4M
Cash flow
- Operating cash flow
- $388.3M
- Investing cash flow
- -$59.3M
- Financing cash flow
- -$432.8M
- Net cash flow
- -$103.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $5.9B
- P/E ratio
- 23.9
- EPS (diluted)
- $18.34
- Dividend yield
- 0.55%
- Shares outstanding
- 13.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 1, 1972
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $265.2M in FY2025.
- Revenue grew 18% from FY2021 to FY2025.
- Gross margin of 32.5%, net margin 10.5%.
- Trading 24% below its 52-week high.
- Pays a dividend yielding about 0.55% annually.
- Valued at a price-to-earnings (P/E) ratio of 23.9.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review CHEMED CORP.
Write a review
News about CHEMED CORP
News & sentiment via Polygon.io